Improving the American Drug Supply Chain Act of 2020
USA116th CongressHR-8588| House
| Updated: 10/13/2020
Richard Hudson
Republican Representative
North Carolina
Cosponsors (1)
Foreign Affairs Committee, Energy and Commerce Committee
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Improving the American Drug Supply Chain Act of 2020 This bill requires the Department of Health and Human Services to enter into an agreement with the National Academies of Sciences, Engineering, and Medicine to (1) study the current and historical production of drugs and key ingredients in the United States and in foreign countries, and (2) formulate recommendations for promoting increased production of drugs and key ingredients in the United States.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Foreign Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Health
Congressional oversightDrug safety, medical device, and laboratory regulationEconomic performance and conditionsEmergency medical services and trauma careEmergency planning and evacuationGovernment studies and investigationsHealth care costs and insuranceHealth technology, devices, suppliesIntellectual propertyLabor marketManufacturingPrescription drugs
Improving the American Drug Supply Chain Act of 2020
USA116th CongressHR-8588| House
| Updated: 10/13/2020
Improving the American Drug Supply Chain Act of 2020 This bill requires the Department of Health and Human Services to enter into an agreement with the National Academies of Sciences, Engineering, and Medicine to (1) study the current and historical production of drugs and key ingredients in the United States and in foreign countries, and (2) formulate recommendations for promoting increased production of drugs and key ingredients in the United States.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Foreign Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Richard Hudson
Republican Representative
North Carolina
Cosponsors (1)
Foreign Affairs Committee, Energy and Commerce Committee
Health
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Congressional oversightDrug safety, medical device, and laboratory regulationEconomic performance and conditionsEmergency medical services and trauma careEmergency planning and evacuationGovernment studies and investigationsHealth care costs and insuranceHealth technology, devices, suppliesIntellectual propertyLabor marketManufacturingPrescription drugs